![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, May 06, 2018 10:15:39 AM
As you see in this video below, Biel was supposed to get clearance from the FDA on Allay back in 2009. 9 years later, and Allay has not been approved. Females in the USA were denied the opportunity to use this product drug free pain free for 9 years now with 10s of millions of pain killers taken that are damaging to the liver and many other organs.
Biel recently completed another clinical trial on ALLAY by a highly reputable University and a Principal Investigator (Thomas Justin Clark, Birmingham Women's NHS Foundation Trust). The results of the study were completed recently on April 1, 2018, as shown below.
https://clinicaltrials.gov/ct2/show/NCT03394547
With the May 9 and May 29 upcoming meeting with the FDA, I will be amazed if ALLAY clearance by the FDA is discussed.
It's about Time to Clear ALLAY for OVER THE COUNTER SALE IN THE USA. IT TOOK WAY TOO LONG
" rel="nofollow" target="_blank">https://www.youtube.com/watch?v=
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM